5 Best Performing Stocks in the Last 6 Months

Page 5 of 5

1. Reata Pharmaceuticals, Inc. (NASDAQ:RETA)

6-Month Share Price Gains as of August 15: 297.92%

Number of Hedge Fund Holders: 31

Reata Pharmaceuticals, Inc. (NASDAQ:RETA) is a biopharmaceutical company in the clinical stage, focused on discovering, creating, and bringing to market innovative treatments for individuals suffering from severe or life-threatening medical conditions. It is a top performing stock as of the last 6 months. On July 28, Reata Pharmaceuticals, Inc. (NASDAQ:RETA) reported that Biogen Inc. (NASDAQ:BIIB) agreed to buy Reata Pharmaceuticals (NASDAQ:RETA) for $172.50 per share in cash, or an enterprise value of about $7.3 billion. The purchase is expected to be finalized during the fourth quarter of 2023.

According to Insider Monkey’s first quarter database, 31 hedge funds were bullish on Reata Pharmaceuticals, Inc. (NASDAQ:RETA), the number increasing from the preceding quarter when 24 hedge funds were invested in Reata Pharmaceuticals, Inc. (NASDAQ:RETA). Joseph Edelman’s Perceptive Advisors held the largest stake in the company, with over 2.1 million shares worth $197.2 million.

Follow Reata Pharmaceuticals Inc (NASDAQ:RETA)

Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily enewsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below. You can also check out Jim Chanos’ 10 Short Positions in 2023 and 11 Cheap Bank Stocks To Buy Before They Take Off.

Page 5 of 5